Indian Pharma Billionaire Dilip Shanghvi Doubles Down On The U.S. With $11.8 Billion Acquisition - Forbes
Indian Pharma Billionaire Dilip Shanghvi Doubles Down On The U.S. With $11.8 Billion Acquisition Forbes
ORIGINAL SOURCE →via M&A News (GN)
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · IN
- [FINANCE] Indian fintech Mobikwik gets approval to launch lending business
- [CONFLICT] Bengal polls: Will Muslim factor shape Kolkata's fate? Tracking the pulse of voters
- [CONFLICT] Dinesh Trivedi appointed India's next Envoy to Dhaka
- [TECH] New Income Tax E-Filing Portal 2026: Karsati AI, Form Wizard, and What Changed
- [CONFLICT] India's summer arrives early, and a Super El Nino is brewing
- [ENERGY] India names BJP leader envoy to Bangladesh as ties thaw